Martin Olovsson

Martin Olovsson has a diverse range of work experience. Martin is currently the CEO and co-founder of OnDosis, where they aim to revolutionize medication dosing through the combination of pharmaceuticals and technology. Martin also serves as a Board Member for AQILION AB, WntResearch AB, and ScientificMed, contributing their expertise to these companies. In the past, Martin worked at AstraZeneca in various roles, including Global VP Inhaled Respiratory franchise and Marketing Company President. Additionally, they have served as a Board Member for The Swedish Association of the Pharmaceutical Industry, LIF.

Martin Olovsson completed their education with the following chronology of academic pursuits:

From 2013 to 2014, they attended the Transformational Leadership Program and Executive Program at Harvard Business School Executive Education.

In 2002, Martin Olovsson attended The Wharton School, where they focused on Leading the Effective Salesforce.

Between 1988 and 1992, they pursued a Bachelor of Science degree in Business Administration and Management, General at Lund University.

Lastly, Martin Olovsson earned an Engineer's degree in Electronics from Tycho Braheskolan, graduating in the period of 1983 to 1987.